Amount Raised
86
49
Amount Raised
Growth Score 86 in past quarter
-4 pts
Heat Score 49 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
- Michael Koby: Co-Founder & PartnerPast Role: Palm Ventures, Managing Director
- Craig Matturro: PrincipalPast Role: 1315 Capital, Vice President
About the Company
1315 Capital provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies, the latter including businesses focused on cost containment and digital health. We believe that these investment areas are attractive largely due to numerous niche market sub-segments and business
models where high-quality management teams can rapidly grow small platform companies, in a capital efficient way, into large and important businesses. The firm targets $10-$20 million investments in commercial healthcare entities that have the potential to scale to approximately $100 million of revenue, a highly attractive level for acquisition or to access the public markets.
Women Founded
